| Product Code: ETC9396947 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Antimicrobial Resistance Diagnostics Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Antimicrobial Resistance Diagnostics Market - Industry Life Cycle |
3.4 South Korea Antimicrobial Resistance Diagnostics Market - Porter's Five Forces |
3.5 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.7 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 South Korea Antimicrobial Resistance Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antimicrobial resistance in South Korea |
4.2.2 Growing awareness about the importance of timely and accurate diagnostics for antimicrobial resistance |
4.2.3 Government initiatives and policies promoting the use of advanced diagnostics technologies |
4.3 Market Restraints |
4.3.1 High cost associated with antimicrobial resistance diagnostics tests |
4.3.2 Limited accessibility to advanced diagnostic technologies in certain regions of South Korea |
4.3.3 Resistance from healthcare professionals to adopt new diagnostic methods |
5 South Korea Antimicrobial Resistance Diagnostics Market Trends |
6 South Korea Antimicrobial Resistance Diagnostics Market, By Types |
6.1 South Korea Antimicrobial Resistance Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Microbiology Culture, 2021- 2031F |
6.1.4 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Immunoassay, 2021- 2031F |
6.1.5 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.6 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F |
6.1.7 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Mass Spectrometry, 2021- 2031F |
6.1.8 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Rapid & Point of Care, 2021- 2031F |
6.2 South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen |
6.2.1 Overview and Analysis |
6.2.2 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Streptococcus Pneumoniae (DRSP), 2021- 2031F |
6.2.3 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Campylobacter (DRC), 2021- 2031F |
6.2.4 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Clostridium Difficile (CD), 2021- 2031F |
6.2.5 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Methicillin Resistant Staphylococcus Aureus (MRSA), 2021- 2031F |
6.2.6 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Neisseria Gonorrhoeae (DRNG), 2021- 2031F |
6.2.7 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Drug Resistant Salmonella (DRNTS), 2021- 2031F |
6.3 South Korea Antimicrobial Resistance Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.5 South Korea Antimicrobial Resistance Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Antimicrobial Resistance Diagnostics Market Import-Export Trade Statistics |
7.1 South Korea Antimicrobial Resistance Diagnostics Market Export to Major Countries |
7.2 South Korea Antimicrobial Resistance Diagnostics Market Imports from Major Countries |
8 South Korea Antimicrobial Resistance Diagnostics Market Key Performance Indicators |
8.1 Rate of adoption of advanced antimicrobial resistance diagnostics technologies |
8.2 Number of research and development collaborations in the field of antimicrobial resistance diagnostics |
8.3 Percentage of healthcare facilities in South Korea equipped with the latest diagnostic tools for antimicrobial resistance |
9 South Korea Antimicrobial Resistance Diagnostics Market - Opportunity Assessment |
9.1 South Korea Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 South Korea Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.3 South Korea Antimicrobial Resistance Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 South Korea Antimicrobial Resistance Diagnostics Market - Competitive Landscape |
10.1 South Korea Antimicrobial Resistance Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 South Korea Antimicrobial Resistance Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here